NFKB1 and cancer: The abnormal increase in NF-κB activity leads to the activation of the Bcl-2 promoter, which ultimately leads to the acceleration of the proliferation and division of cancer cells via inhibition of apoptosis, which is an important reason for Gem resistance (Jin, 2013).